C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
01/2000
01/04/2000	US6011175 Inhibition of farnesyltransferase
01/04/2000	US6011152 Reacting stoichiometric amounts or more of an amino carboxylic acid or a protected/activated for thereof with an activated dervative selected from the group consisting of oxalates and malonates in the presence of a solvent and heat
01/04/2000	US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
01/04/2000	US6011045 Inhibitors of bone resorption; anticancer agents
12/1999
12/29/1999	WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
12/29/1999	WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors
12/29/1999	WO1999031079A3 Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents
12/29/1999	EP0966465A1 Inhibitors of impdh enzyme
12/29/1999	EP0966447A1 Small molecules useful in the treatment of inflammatory disease
12/29/1999	EP0612314B1 2-pyrazinylethylamine derivatives and their use as pharmaceuticals
12/29/1999	CN1239889A Novel compounds useful as neuro-protective agents
12/29/1999	CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion
12/29/1999	CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/28/1999	US6008237 Potent agonists of peroxidsome proliferator activated receptor; for controlling or preventing of diabetes, hyperglycemia, hyperlipidemia, hypercholesterolemia, atherosclerosis, obesity, vascular restenosis
12/28/1999	US6008176 As textile detergent builders in powder detergent formulations and as calcium sequestrants in oral hygiene products
12/23/1999	WO1999065886A1 Benzazole compounds and their use
12/23/1999	WO1999065871A2 Thiolesters and uses thereof
12/23/1999	CA2335464A1 Novel thiolesters and uses thereof
12/23/1999	CA2330977A1 Benzazole compounds and their use
12/22/1999	EP0964863A1 Oxazolidines as 5-ht2a-antagonists
12/22/1999	EP0964851A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion
12/22/1999	EP0904077A4 Methods for the preparation of biphenyl isoxazole sulfonamides
12/22/1999	EP0733033B1 Pharmaceutically active substituted aromatic compounds
12/21/1999	US6005141 Use of glycine-N,N-diacetic acid derivatives as biodegradable complexing agents for alkaline earth metal ions and heavy metal ions and process for the preparation thereof
12/21/1999	US6004994 Antiinflammatory agents, cyclooxygenase inhibitors and analgesics
12/21/1999	US6004992 Compounds as pesticides, nematocides, miticide from ester derivatives
12/21/1999	US6004977 N-(pyridinylamino) isoindolines and related compounds
12/21/1999	US6004903 2-Anylocyclohexanediones having improved herbicidal properties
12/21/1999	US6004536 Lipophilic cyanine dyes with enchanced aqueous solubilty
12/16/1999	WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999	WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	WO1999064051A1 Novel antibacterial compounds
12/16/1999	WO1999064049A1 Novel antibacterial agents
12/16/1999	WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999	WO1999064047A1 Novel antiviral compounds
12/16/1999	WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999	WO1999064038A1 Novel analgesic agents
12/16/1999	WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999	WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	WO1999063999A1 H1-histamine receptor antagonists
12/16/1999	WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999	WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999	WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2321274A1 Novel antiviral compounds
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999	CA2321162A1 Novel antibacterial compounds
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2320241A1 Multivalent macrolide antibiotics
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999	CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2316999A1 Inhibitors of hiv reverse transcriptase
12/15/1999	EP0923556A4 An asymmetric conjugate addition reaction
12/15/1999	EP0767780B1 Amino acid derivatives and their use as pesticides
12/15/1999	CN1238767A 4-cyclohexyl phenyl-oxazolines and their use for controlling animal pests
12/15/1999	CN1238760A N-(aryl/heteroaryl/alkyl acetyl) amino acid esters, pharmaceutical composition comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
12/14/1999	US6002014 Selectively inhibiting the action of cox-2; treating inflammation
12/14/1999	CA2136007C Novel compound with platelet aggregation inhibitor activity
12/09/1999	WO1999062888A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
12/09/1999	WO1999062872A1 New 3-aryl-2-hydroxypropionic acid derivative (i)
12/09/1999	WO1999062520A1 Hiv integrase inhibitors
12/09/1999	WO1999062506A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/09/1999	WO1999062504A2 Topical administration of oxazolidinones for transdermal delivery
12/09/1999	CA2333964A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
12/09/1999	CA2333707A1 Hiv integrase inhibitors

1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 210